<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04324853</url>
  </required_header>
  <id_info>
    <org_study_id>PROT N°038/2018/SG/CNE</org_study_id>
    <nct_id>NCT04324853</nct_id>
  </id_info>
  <brief_title>Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study</brief_title>
  <acronym>HELMVIT</acronym>
  <official_title>Assessing the Effect of Maternal Helminth Infection on Vitamin D Regulation and on the Immune System of the Infant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche Médicale de Lambaréné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre de Recherche Médicale de Lambaréné</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To examine whether helminth infection during pregnancy alters Vitamin-D-metabolism
      and reactivity of the child's immune system

      Hypothesis: Helminth infection during pregnancy is associated with altered Vitamin D levels
      and Vitamin D receptor expression in the placenta and modified immune reactivity in the
      infant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives The primary objective of the proposed research project is to study the impact of
      helminth infection in general and particularly of infection with S. haematobium during
      pregnancy on Vitamin D metabolism and its related factors as well as the impact of maternal
      infection on infants developing immune system and health.

      Specific Objectives To assess the effect of maternal helminths infections on Vitamin D and
      vitamin-D-related factors in the serum of pregnant women and cord blood of their infants,

      To assess the effect of helminth infection on placental biology:

      Determine expression levels of VDR and inflammatory genes Investigate histologically the
      gestational age and other functional aspects of the placenta Determine the influence of
      helminth driven inflammation and helminth antigens on placental tissue by establishing a
      (co-)culture system using primary placental cells and a placental cell line To assess whether
      helminth infections influence the infant's peripheral immune system by analyzing composition,
      reactivity and lineage determination of fetal cord blood mononuclear cells (CBMCs) in
      relation to the maternal and fetal immune and Vitamin D status.

      Current study focusing objectives In the present study the investigators explore if and how
      Vitamin D and its related signals are modulated by helminth infection and how helminth
      infection could thereby shape the developing immune system of the newborn by analyzing CBMCs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 28, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between Schistosoma and helminth infection and Vitamin D levels.</measure>
    <time_frame>48 Months</time_frame>
    <description>Schistosoma hematobium in preganancy is associated with vitamin D metabolism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between Schistosoma infection and intrauterine growth restriction (IUGR) (defined as birth weight below the 10th birth weight percentile), stillbirth and premature delivery.</measure>
    <time_frame>48 Months</time_frame>
    <description>Schistosoma hematobium infection during pregnancy is associated with a birth weight born child</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Immunosuppression</condition>
  <arm_group>
    <arm_group_label>S. haematobium positive</arm_group_label>
    <description>Preganant women infected with Schistosomia hematobium alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>geohelminths positive</arm_group_label>
    <description>pregnant women infected with geohlminths alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Helminth negative</arm_group_label>
    <description>Pregnant women free of anyn helminths infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microscopy ( Urine filtration), UCAA test, qPCR,</intervention_name>
    <description>Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma.Schistosomiasis is prevalent in tropical and subtropical areas, especially in poor communities without access to safe drinking water and adequate sanitation.</description>
    <arm_group_label>S. haematobium positive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,</intervention_name>
    <description>Soil-transmitted helminth infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor.</description>
    <arm_group_label>Helminth negative</arm_group_label>
    <arm_group_label>geohelminths positive</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      S. haematobium will be assessed using urine filtration technique, intestinal parasites will
      be determined using the Kato-Katz method as well as different culture methods

      According to their infection status, women will be allocated to the following groups: S.
      haematobium positive, geohelminths positive and helminth negative participants.

      Plasma and peripheral blood mononuclear cells (PBMCs) are prepared and stored at -150°C;
      serum will be collected and immediately frozen in lightproof vials at -80 °C until further
      analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The target population is pregnant women coming to the ante natal clinics (ANC) for routine
        visits or to obtain medical care in the obstetrics department of the Albert Schweitzer
        Hospital (ASH) as well as at Georges Rawiri General Hospital (GRGH), both situated in
        Lambaréné. The pregnant women originally from areas endemic for Schistosomiasis and
        Soil-transmitted helminths will be invited to participate into the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women attending antenatal care from Lambaréné and Fougamou areas

          -  Pregnant women who have given written informed consent to the study for herself and
             for her unborn child and live infant.

        Exclusion Criteria:

          -  Known of chronic infections and diseases(e.g. diabetes, HIV, Hepatitis B and C,
             anemia).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayola A ADEGNIKA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche Médicale de Lambaréné</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meral Esen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clarissa DaCosta, MD</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ayola A Adegnika, MD, PhD</last_name>
    <phone>+24177406464</phone>
    <email>aadegnika@cermel.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Josiane Y Honkpehedji, MD</last_name>
    <phone>+24174584616</phone>
    <email>josiane.h@cermel.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Josiane Y Honkpehedji</name>
      <address>
        <city>Lambaréné</city>
        <state>Moyen Ogooué</state>
        <zip>BP 242</zip>
        <country>Gabon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josiane Y HONKPEHEDJI, MD</last_name>
      <phone>+24174584616</phone>
      <email>josiane.h@cermel.org</email>
    </contact>
    <contact_backup>
      <last_name>Romual B MBA, MSc</last_name>
      <phone>+24162643627</phone>
      <email>romuald.beh@cermel.org</email>
    </contact_backup>
    <investigator>
      <last_name>Josiane HONKPEHEDJI, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Claude DEJON AGOBE, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Gabon</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>March 28, 2020</last_update_submitted>
  <last_update_submitted_qc>March 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Helminth</keyword>
  <keyword>Schistosomiasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Helminthiasis</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

